JSA advised Unipath Specialty Laboratory Limited on the Joint Venture with Dr. Sanjay Jayantilal Mehta wherein Unipath acquired initial 51% equity share capital and 100% of redeemable convertible preference shares of Dr. Sanjay Mehta Unipath Speciality Laboratory Private Limited, an entity engaged in providing render pathology and radiology services. The transaction is structured in multi-independent tranches resulting in acquisition of 100% equity shares of Dr. Sanjay Mehta Unipath Speciality Laboratory Private Limited by Unipath Specialty Laboratory Limited. Unipath Specialty Laboratory Limited has successfully established itself as one of the leading diagnostic brands in Western India having successfully expanded across 11 states.
Our deal team comprised Partner, Rinku Ambekar and Principal Associate, Reshma Oak.
Rinku has a diverse corporate practice focused on cross-border M&A representing clients in the United States, Europe, Singapore, Malaysia, Japan, Australia, United Kingdom and her experience extends to takeovers, buyouts, private equity transactions, creation of joint ventures, strategic alliances, stock acquisitions, business acquisitions, asset acquisitions, restructurings, corporate governance, commercial and corporate agreements.